Shanghai, July 31- GSK has announced today that the country’s first approved cervical cancer vaccine Cervarix has officially come onto the market.

The first batch of imported Cervarix has passed the inspection of the National Quality Inspection Department.

The vaccine is now available in community hospitals and community health service centers.